Pro Research Updates

Our research updates, often shorter in length, are conveyed through initial and ongoing coverage of our catalog of stocks. With thousands of original research pieces and updates under our belt, we have an archival system of keeping the history of our coverage intact and easy to find. For examples of how you will receive this research please see a few case studies showing the chronology of a few notable stocks.

Below you can find the most recent stocks that we have issued original research on, or updates to original research.

Log in below with your Premium Account to see the most recent coverage.

The FULL list of Spotlight Research can be found HERE, which has years of coverage and updates – all archived for your reference. Feel free to use the Advanced Filter at that page to quickly find coverage on stock of interest.

Testimonials

Latest Stock Coverage

Electrocore, Inc. (ECOR)

ECOR Information Arbitrage Lands The Stock On GeoInvesting’s Reasons For Tracking List We don’t currently own any shares in $ECOR. However, we wanted to briefly discuss a little Information Arbitrage (wait for it) we recently came across. ECOR Makes and markets the gammaCore medical device: “gammaCoreTM (nVNS) is the first non-invasive, hand-held medical therapy applied at th...

Counterpath Corporation (CPAH)

New Reasons For Tracking - CPAH Below is a quick Reasons For Tracking overview from GeoMember, Shalin Patel, on CounterPath Corporation (NASDAQ:CPAH) a global provider of Unified Communications and Collaboration (UCC) solutions for enterprises and service providers. Given our coverage On UCaaS players, $ATGN and $CXDO, we are eager to follow CPAH's transformation to a cloud communication pl...

Educational Development Corpora (EDUC)

Added to our EDUC Long Position On May 29, 2020, we disclosed that we initiated a small position in the EDUC, based on some information arbitrage we came across in the Q4 2020 Conference call transcript. We are still not comfortable making the stock a core position and are treating it as a short term holding going into the release of Q1 2021. However, we do believe that some of the commentary in...

Tel-Instrument Electronics (TIKK)

Tel-Instrument Electronics (OOTC:TIKK) ($3.40, $11.0M market cap) (aerospace & defense) announced Q4 2020 results, where commercial revenue was negatively impacted by COVID-19: Sales of $3.8 million vs $4.1 million in the prior year Non-GAAP EPS $0.10 vs $0.13 in the prior year Full year sales of $15.7 million vs $12.1 million in the prior year Full year non-GAAP EPS of $0.35 vs a los...

Altimmune, Inc. (ALT)

Altimmune (NASDAQ:ALT) ($10.60, $213.1M market cap, was marked up 20% this morning), a clinical stage biopharmaceutical company, received funding worth $4.7 million from US DoD to help it move ahead with the Phase 1/2 clinical trial of T-COVID, an investigational intranasal immune modulator for the treatment of outpatients with early COVID-19. The funding is expected to provide ALT sufficient liqu...

Viewing page 1 of 4|Next Page